Stay updated with breaking news from B Moderna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A COVID-19 vaccine for the youngest children could be available by June as federal regulators line up a late-spring sprint to expand protection to all Americans.
Moderna asked the Food and Drug Administration to authorize its COVID-19 vaccine for children age 5 and younger, intensifying the race to immunize the 19 million Americans who remain ineligible for shots against the disease.
Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year.
The director of the Centers for Disease Control and Prevention said they are tracking the omicron sub-variant that caused spikes overseas but the strain, while fast-moving, does not appear to make infected persons any sicker and is not straining hospital capacity.
Drugmaker Moderna said Wednesday it will seek emergency authorization of a COVID-19 vaccine for children under 6 years old, touting preliminary data showing it produced an immune response similar to that of larger doses for young adults.